Third Quarter Fiscal 2011 Business and Financial Highlights
- Quarterly revenue up 216% year-over-year; 51% quarter over quarter
- Quarterly revenue of $100.3 million; non-GAAP customer licensing income of $91.6 million
- GAAP diluted income per share of $0.00; non-GAAP diluted income per share of $0.12
- Signed Differential Power Analysis patent license agreement with major smartphone and tablet manufacturer
- Verimatrix licensed CryptoFirewall™ core for Pay TV solutions
- Rambus Labs brings on Dr. David Stork, a computational sensing and imaging expert
SUNNYVALE, CALIFORNIA, UNITED STATES – 10/20/2011 – Rambus Inc. (NASDAQ:RMBS), one of the world’s premier technology licensing companies, today reported financial results for the third quarter ended September 30, 2011.
GAAP Financial Results:
Revenue for the third quarter of 2011 was $100.3 million, up 51% sequentially from the second quarter of 2011 primarily due to the recognition of royalties from new licensing agreements signed in the second and third quarter of 2011. As compared to the third quarter of 2010, revenue was up 216% primarily due to the revenue recognized from agreements signed since the third quarter of 2010. Revenue for the nine months ended September 30, 2011 was $229.0 million, down 2% over the same period of last year, due to the recognition during the first quarter of 2010 of revenue from the settlement agreement signed with Samsung Electronics Co., Ltd. (“Samsung”), partially offset by the revenue recognized from agreements signed since the third quarter of 2010.
Total operating costs and expenses for the third quarter of 2011 were $89.5 million, which included general litigation expenses of $23.5 million, $7.2 million of stock-based compensation expenses and retention bonuses and amortization expenses related to the acquisition of Cryptography Research Inc. (“CRI”) of $12.7 million. This is compared to total operating costs and expenses for the second quarter of 2011 of $68.7 million, which included general litigation expenses of $11.5 million, $7.0 million of stock-based compensation expenses and CRI related deal costs, retention bonuses and amortization expenses of $8.4 million. Total operating costs and expenses in the third quarter of 2010 were $43.2 million, which included general litigation expenses of $4.6 million, $7.5 million of stock-based compensation expenses and gain from the Samsung settlement of $10.3 million.
Total operating costs and expenses for the nine months ended September 30, 2011 were $212.4 million, which included a $6.2 million gain related to the Samsung settlement, $21.5 million of stock-based compensation expenses and $2.7 million for previous stock-based compensation restatement and related legal expenses. This is compared to total operating costs and expenses of $48.5 million for the same period of 2010, which included a $116.5 million gain related to the Samsung settlement, $23.2 million of stock-based compensation expenses and $3.4 million for previous stock-based compensation restatement and related legal expenses. General litigation expenses for the nine months ended September 30, 2011 were $44.2 million, an increase of $27.4 million from the same period in 2010.
Net income for the third quarter of 2011 was $0.5 million as compared to a net loss of $10.6 million in the second quarter of 2011 and a net loss of $20.6 million in the third quarter of 2010. Diluted net income per share for the third quarter of 2011 was $0.00 as compared to a net loss per share of $0.10 in the second quarter of 2011 and a net loss per share of $0.18 in the third quarter of 2010.
Net loss for the nine months ended September 30, 2011 was $14.3 million as compared to a net income of $117.8 million for the same period of 2010. Diluted net loss per share for the nine months ended September 30, 2011 was $0.13 as compared to a net income per share of $1.01 for the same period of 2010.
Non-GAAP Financial Results (1):
Customer licensing income in the third quarter of 2011 was $91.6 million as compared to $73.0 million in the second quarter of 2011 and $42.0 million in the third quarter of 2010. Customer licensing income for the nine months ended September 30, 2011 was $233.3 million as compared to $349.0 million in the same period of 2010.
Non-GAAP operating costs and expenses in the second quarter of 2011 were $66.8 million as compared to $50.6 million in the second quarter of 2011 and $43.5 million in the third quarter of 2010. Non-GAAP operating costs and expenses for the nine months ended September 30, 2011were $167.4 million as compared to $134.8 million in the same period of 2010.
Non-GAAP operating income in the third quarter of 2011 was $24.8 million as compared to $22.3 million in the second quarter of 2011 and an operating loss of $1.5 million in the third quarter of 2010. Non-GAAP operating income for the nine months ended September 30, 2011 was $65.9 million as compared to $214.2 million in the same period of 2010.
Non-GAAP net income in the third quarter of 2011 was $14.0 million as compared to $12.4 million in the second quarter of 2011 and net loss of $2.1 million in the third quarter of 2010. Non-GAAP net income for the nine months ended September 30, 2011 was $36.6 million as compared to $133.6 million in the same period of 2010.
Other Financial Highlights:
Cash, cash equivalents, and marketable securities as of September 30, 2011 were $292.7 million, a decrease of approximately $66.7 million from June 30, 2011. During the third quarter of 2011, Samsung exercised its put option in accordance with the terms of a stock purchase agreement dated January 19, 2010. As a result, the Company was required to repurchase 4.8 million shares of the Company’s common stock for $100.0 million.
During the third quarter of 2011, the Company recorded an income tax provision of approximately $4.1 million. As the Company continues to maintain a full valuation allowance against its U.S. deferred tax assets, the Company’s tax provision consists of primarily withholding taxes and current state and foreign taxes.
The Company will host a conference call today at 2:00 p.m. PT today to discuss its financial results. The call, audio and slides will be available online at http://investor.rambus.com/events.cfm. A replay will be available following the call on Rambus’ Investor Relations website or for one week at the following numbers: (855) 859-2056 (domestic) or (404) 537-3406 (international) with ID# 18184950.
(1) Non-GAAP Financial Information:
In the commentary set forth above and/or in the financial statements included in this earnings release, the Company presents the following non-GAAP financial measures: customer licensing income, operating costs and expenses, operating income (loss) and net income (loss). In computing each of these non-GAAP financial measures, the Company combined revenue and gain from settlement and excluded charges or gains relating to: stock-based compensation expenses, CRI related deal costs and retention bonus expense, amortization expenses, costs of restatement and related legal activities and non-cash interest expense. The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results should be carefully evaluated. Management believes the non-GAAP financial measures are appropriate for both its own assessment of, and to show investors, how the Company’s performance compares to other periods. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. Reconciliation from GAAP to non-GAAP results is included in the financial statements contained in this release.
Our non-GAAP financial measures reflect adjustments based on the following items:
Customer licensing income. Customer licensing income includes the Company’s measure of the total cash royalties received from our customers under our licensing agreements with them. Prior to the second quarter of 2011, the Company bifurcated royalty payments that it received from Samsung between revenue and gain from settlement, which was reflected as a contra expense in operating expenses. The Company has combined revenue from our customers, including Samsung, and the gain from the Samsung settlement as customer licensing income to reflect the total amounts received from our customers, including Samsung under the relevant agreements. In addition, for the second quarter of 2011, the Company had also included in customer licensing income a patent royalty cash payment received from a customer pursuant to executed agreements; this payment had not been recognized as revenue in the second quarter of 2011 as not all revenue recognition criteria were met during the quarter. Upon meeting all of the revenue recognition criteria, the Company recognized this cash payment as revenue in the third quarter of 2011. Also in the third quarter of 2011, the Company received patents transferred from a customer as part of the consideration for the patent royalty payment. As this is non-cash revenue, the Company excluded it from customer licensing income. Additionally, in the third quarter of 2011, the Company received patent royalty payments from certain patent license agreements assumed in the acquisition with CRI which were treated as favorable contracts. Cash received from these acquired favorable contracts reduced the favorable contract intangible asset on the Company’s balance sheet. The Company has combined these cash royalty payments as customer licensing income to reflect the total amounts received from our customers.
Stock-based compensation expense. These expenses consist primarily of expenses related to employee stock options, employee stock purchase plans, and employee non-vested equity stock and non-vested stock units. The Company excludes stock-based compensation expense from its non-GAAP measures primarily because they are non-cash expenses that the Company does not believe are reflective of ongoing operating results. Additionally, given the fact that other companies may grant different amounts and types of equity awards and may use different option valuation assumptions, excluding stock-based compensation expense permits more accurate comparisons of the Company’s results with other peer companies.
CRI related deal costs and retention bonus expense. These expenses include all direct acquisition costs of CRI and the current periods’ portion of the $50.0 million retention bonus expense which is payable to certain legacy CRI employees and contractors. The Company excludes these expenses in order to provide better comparability between periods.
Amortization expense. The Company incurs expenses for the amortization of intangible assets in connection with acquisitions. The Company excludes these items because these expenses are not reflective of ongoing operating results in the period incurred. These amounts arise from the Company’s prior acquisitions and have no direct correlation to the core operation of the Company’s business.
Costs of restatement and related legal activities. These expenses consist primarily of investigation, audit, legal and other professional fees related to the 2006-2007 stock option investigation and related litigation, as well as recoveries received from third parties. The Company excludes these costs and recoveries from its non-GAAP measures primarily because the Company believes that these non-recurring costs and recoveries have no direct correlation to the core operation of the Company’s business.
Non-cash interest expense. The Company incurs non-cash interest expense related to its convertible notes. The Company excludes non-cash interest expense related to its convertible notes to provide more accurate comparisons of the Company’s results with other peer companies and to more accurately reflect the Company’s on-going operations.
Income tax adjustments. For purposes of internal forecasting, planning and analyzing future periods that assumes net income from operations, the Company estimates a fixed, long-term projected tax rate of approximately 36 percent. Accordingly, the Company has applied the 36 percent tax rate to its non-GAAP financial results to assist the Company’s planning for future periods.
On occasion in the future, there may be other items, such as significant asset impairments, restructuring charges or significant gains or losses from contingencies that the Company may exclude if it believes that doing so is consistent with the goal of providing useful information to investors and management.
About Rambus Inc.:
Rambus is one of the world’s premier technology licensing companies. As a company of inventors, Rambus focuses on the development of technologies that enrich the end-user experience of electronic systems. Additional information is available at www.rambus.com.
| Condensed Consolidated Balance Sheets (In thousands) (Unaudited) |
||
| September 30, 2011 | December 31, 2010 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 160,844 | $ 215,262 |
| Marketable securities | 131,909 | 296,747 |
| Accounts receivable | 917 | 2,600 |
| Prepaids and other current assets | 10,101 | 10,898 |
| Deferred taxes | 1,863 | 2,420 |
| Total current assets | 305,634 | 527,927 |
| Deferred taxes, long-term | 7,190 | 2,974 |
| Intangible assets, net | 189,363 | 40,986 |
| Goodwill | 115,148 | 18,154 |
| Property, plant and equipment, net | 72,494 | 67,770 |
| Other assets | 5,640 | 5,361 |
| Total assets | $ 695,469 | $ 663,172 |
| Liabilities, Contingently Redeemable Common Stock & Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $ 18,117 | $ 5,952 |
| Accrued salaries and benefits | 27,488 | 31,634 |
| Accrued litigation expenses | 9,830 | 4,060 |
| Deferred revenue | 762 | 2,482 |
| Other accrued liabilities | 10,132 | 11,683 |
| Total current liabilities | 66,329 | 55,811 |
| Long-term liabilities: | ||
| Convertible notes, long-term | 130,354 | 121,500 |
| Long-term imputed financing obligation | 36,386 | 27,899 |
| Other long-term liabilities | 13,440 | 9,679 |
| Total long-term liabilities | 180,180 | 159,078 |
| Contingently redeemable common stock | – | 113,500 |
| Total stockholders’ equity | 448,960 | 334,783 |
| Total liabilities, contingently redeemable common stock and stockholders’ equity | $ 695,469 | $ 663,172 |
| Condensed Consolidated Statements of Operations (In thousands, except per share amounts) (Unaudited) |
||||
| Three Months Ended September 30, |
Nine Months Ended September 30, |
|||
| 2011 | 2010 | 2011 | 2010 | |
| Revenue: | ||||
| Royalties | $ 96,216 | $ 31,179 | $ 216,421 | $ 229,913 |
| Contract revenue | 4,047 | 564 | 12,583 | 2,556 |
| Total revenue | 100,263 | 31,743 | 229,004 | 232,469 |
| Operating costs and expenses: | ||||
| Cost of revenue (1) | 7,425 | 1,368 | 16,632 | 5,026 |
| Research and development (1) | 32,318 | 23,002 | 79,855 | 67,678 |
| Marketing, general and administrative (1) | 48,952 | 27,938 | 119,416 | 88,873 |
| Costs of restatement and related legal activities | 832 | 1,229 | 2,703 | 3,393 |
| Gain from settlement | – | (10,300) | (6,200) | (116,500) |
| Total operating costs and expenses | 89,527 | 43,237 | 212,406 | 48,470 |
| Operating income (loss) | 10,736 | 11,494 | 16,598 | 183,999 |
| Interest income and other income (expense), net | (768) | 312 | (2,197) | 1,053 |
| Interest expense on convertible notes | (5,410) | (4,953) | (15,794) | (14,709) |
| Interest and other income (expense), net | (6,178) | (4,641) | (17,991) | (13,656) |
| Income (loss) before income taxes | 4,558 | (16,135) | (1,393) | 170,343 |
| Provision for income taxes | 4,080 | 4,441 | 12,944 | 52,510 |
| Net income (loss) | $ 478 | $ (20,576) | $ (14,337) | $ 117,833 |
| Net income (loss) per share: | ||||
| Basic | $ 0.00 | $ (0.18) | $ (0.13) | $ 1.04 |
| Diluted | $ 00.00 | $ (0.18) | $ (0.13) | $ 1.01 |
| Weighted average shares used in per share calculation | ||||
| Basic | 112,334 | 111,866 | 109,997 | 112,768 |
| Diluted | 115,552 | 111,866 | 109,997 | 116,347 |
| (1) Total stock-based compensation expense for the three and nine month periods ended September 30, 2011 and 2010 are presented as follows: | ||||
| Three Months Ended September 30, |
Nine Months Ended September 30, |
|||
| 2011 | 2010 | 2011 | 2010 | |
| Cost of revenue | $ 90 | $ 17 | $ 499 | $ 146 |
| Research and development | $ 2,775 | $ 2,470 | $ 7,777 | $ 7,742 |
| Marketing, general and administrative | $ 4,354 | $ 4,976 | $ 13,262 | $ 15,340 |
| Supplemental Reconciliation of GAAP to Non-GAAP Results (In thousands) (Unaudited) |
||||||
| Three Months Ended | Nine Months Ended | |||||
| September 30, 2011 | June 30, 2011 | September 30, 2010 | September 30, 2011 | September 30, 2010 | ||
| Revenue | $ 100,263 | $ 66,214 | $ 31,743 | $ 229,004 | $ 232,469 | |
| Adjustments: | ||||||
| Gain from settlement | – | – | 10,300 | 6,200 | 116,500 | |
| Other patent royalties received | (8,625) | 6,750 | – | (1,875) | – | |
| Total customer licensing income | $ 91,638 | $ 72,964 | $ 42,043 | $ 233,329 | $ 348,969 | |
| Operating costs and expenses | $ 89,527 | $ 68,722 | $ 43,237 | $ 212,406 | $ 48,470 | |
| Adjustments: | ||||||
| Stock-based compensation | (7,219) | (7,029) | (7,463) | (21,538) | (23,228) | |
| CRI related deal costs and retention bonus | (7,702) | (6,335) | – | (14,037) | – | |
| Amortization | (6,927) | (4,003) | (1,299) | (12,909) | (3,587) | |
| Costs of restatement and related legal activities | (832) | (712) | (1,229) | (2,703) | (3,393) | |
| Gain from settlement | – | – | 10,300 | 6,200 | 116,500 | |
| Non-GAAP operating costs and expenses | $ 66,847 | $ 50,643 | $ 43,546 | $ 167,419 | $ 134,762 | |
| Operating income (loss) | $ 10,736 | $ (2,508) | $ (11,494) | $ 16,598 | $ 183,999 | |
| Adjustments: | ||||||
| Other patent royalties received | (8,625) | 6,750 | – | (1,875) | – | |
| Stock-based compensation | 7,219 | 7,029 | 7,463 | 21,538 | 23,228 | |
| CRI related deal costs and retention bonus | 7,702 | 6,335 | – | 14,037 | – | |
| Amortization | 6,927 | 4,003 | 1,299 | 12,909 | 3,587 | |
| Costs of restatement and related legal activities | 832 | 712 | 1,229 | 2,703 | 3,393 | |
| Non-GAAP operating income (loss) | $ 24,791 | $ 22,321 | $ (1,503) | $ 65,910 | $ 214,207 | |
| Income (loss) before income taxes | $ 4,558 | $ (8,497) | $ (16,135) | $ (1,393) | $ 170,343 | |
| Adjustments: | ||||||
| Other patent royalties received | (8,625) | 6,750 | – | (1,875) | – | |
| Stock-based compensation | 7,219 | 7,029 | 7,463 | 21,538 | 23,228 | |
| CRI related deal costs and retention bonus | 7,702 | 6,335 | – | 14,037 | – | |
| Amortization | 6,927 | 4,003 | 1,299 | 12,909 | 3,587 | |
| Costs of restatement and related legal activities | 832 | 712 | 1,229 | 2,703 | 3,393 | |
| Non-cash interest expense on convertible notes | 3,254 | 3,056 | 2,797 | 9,326 | 8,241 | |
| Non-GAAP income (loss) before income taxes | $ 21,867 | $ 19,388 | $ (3,347) | $ 57,245 | $ 208,792 | |
| Non-GAAP provision for income taxes | 7,872 | 6,990 | (1,205) | 20,618 | 75,165 | |
| Non-GAAP net income (loss) | $ 13,995 | $ 12,398 | $ (2,142) | $ 36,627 | $ 133,627 | |
| Non-GAAP basic net income per share | $ 0.12 | $ 0.11 | $ (0.02) | $ 0.33 | $ 1.18 | |
| Non-GAAP diluted net income per share | $ 0.12 | $ 0.11 | $ (0.02) | $ 0.33 | $ 1.15 | |
| Weighted average shares used in per share calculation | ||||||
| Basic | 112,334 | 109,992 | 111,866 | 109,997 | 112,768 | |
| Diluted | 115,552 | 112,067 | 111,866 | 112,525 | 116,347 | |
